// App-Quantinova.ai

TCT-586 : Alirocumab efficacy and safety in patients with prior coronary revascularization

Researchers

Presenter

  • Dean Kereiakes

Principal Investigators

  • Norman Lepor

  • Robert Gerber

  • L. Veronica Lee

  • Desmond Thompson

  • C. Michael Gibson

Medical Centers

  • The Christ Hospital, Cincinnati, Ohio, United States

  • East Sussex Healthcare NHS Trust, Hastings, United Kingdom

  • Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

  • Sanofi, Bridgewater, New Jersey, United States

  • Cedars-Sinai Medical Center/Westside Medical Associates of Los Angeles, Beverly Hills, California, United States

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Alirocumab

  • Ezetimibe

Outcome

  • N/A

Study Design

  • Placebo Control

Phase

  • III

Study Id's

  • NCT01663402

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved